← Back to Search

TASK III for Stroke Caregiver Support

N/A

Recruiting

Led By Tamilyn Bakas, PhD, RN

Research Sponsored by University of Cincinnati

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

No difficulties hearing or talking by telephone or computer

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline to 8 weeks (shortterm), baseline to 12, 24, and 52 weeks (long-term)

Awards & highlights

Study Summary

This trial sought to find out if the TASK III intervention could reduce the burden on caregivers of stroke survivors.

Who is the study for?

This trial is for unpaid family caregivers of stroke survivors who can communicate in English and use a phone or computer. They must be willing to engage in 9 calls with a nurse and 5 interviews, have no severe cognitive impairments, and not care for someone in long-term facilities. Exclusions include caregivers or survivors with certain mental illnesses, substance abuse history, under age 18, incarcerated, pregnant, or terminally ill.Check my eligibility

What is being tested?

The TASK III study tests a caregiver support program against standard information support. Caregivers will either receive the TASK III intervention with skill-building resources and nurse calls or just general information and referrals to help them manage their caregiving responsibilities while maintaining their own health.See study design

What are the potential side effects?

Since this trial involves educational interventions rather than medications, there are no typical drug side effects; however participants may experience emotional distress or fatigue related to the time commitment of engaging with the program materials and follow-up calls.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have no issues with hearing or speaking on the phone or computer.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline to 8 weeks (shortterm), baseline to 12, 24, and 52 weeks (long-term)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline to 8 weeks (shortterm), baseline to 12, 24, and 52 weeks (long-term)

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 8 weeks (shortterm), baseline to 12, 24, and 52 weeks (long-term) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Life Changes

Secondary outcome measures

Depressive Symptoms

Healthcare Utilization

Other Symptoms

+4 more

Other outcome measures

Mediator: Self-efficacy of Diet

Mediator: Self-efficacy of Exercise

Mediator: Task Difficulty

+3 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: TASK III GroupExperimental Treatment1 Intervention

The Telehealth Assessment and Skill-Building Kit (TASK III) group

Group II: ISR GroupActive Control1 Intervention

The Information, Support, and Referral (ISR) group

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of CincinnatiLead Sponsor

428 Previous Clinical Trials

634,090 Total Patients Enrolled

31 Trials studying Stroke

15,928 Patients Enrolled for Stroke

National Institute of Nursing Research (NINR)NIH

580 Previous Clinical Trials

10,376,268 Total Patients Enrolled

15 Trials studying Stroke

7,027 Patients Enrolled for Stroke

Tamilyn Bakas, PhD, RNPrincipal InvestigatorUniversity of Cincinnati

1 Previous Clinical Trials

74 Total Patients Enrolled

1 Trials studying Stroke

74 Patients Enrolled for Stroke

Media Library

Telehealth Assessment and Skill-Building Kit (TASK III) Group Clinical Trial Eligibility Overview. Trial Name: NCT05304078 — N/A

Stroke Research Study Groups: ISR Group, TASK III Group

Stroke Clinical Trial 2023: Telehealth Assessment and Skill-Building Kit (TASK III) Group Highlights & Side Effects. Trial Name: NCT05304078 — N/A

Telehealth Assessment and Skill-Building Kit (TASK III) Group 2023 Treatment Timeline for Medical Study. Trial Name: NCT05304078 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are researchers currently accepting participants for this research endeavor?

"This investigational trial is actively seeking participants, as stated by clinicaltrials.gov. It was first advertised on the 10th of October 2022 and has had its details adjusted most recently on September 26th 2022."

Answered by AI

How many individuals will be included in this investigation?

"Indeed, the latest information on clinicaltrials.gov reveals that enrollment for this medical trial is in progress; it was first made available to potential subjects on October 1st 2022 and revised most recently on September 26th 2022. This experiment requires 296 individuals from a single site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Telehealth Assessment and Skill-Building Intervention for Stroke Caregivers (TASK III)

Tamilyn Bakas 2022. "Telehealth Assessment and Skill-Building Intervention for Stroke Caregivers (TASK III)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05304078.